Insider Selling: 111 (NASDAQ:YI) Director Sells $17,610.00 in Stock

111, Inc. Sponsored ADR (NASDAQ:YI) Director Jun Justin Luo sold 70,440 shares of the firm’s stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $0.25, for a total transaction of $17,610.00. Following the transaction, the director directly owned 710,551 shares in the company, valued at $177,637.75. The trade was a 9.02% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Jun Justin Luo also recently made the following trade(s):

• On Tuesday, May 26th, Jun Justin Luo sold 29,280 shares of 111 stock. The stock was sold at an average price of $0.27, for a total transaction of $7,905.60.

111 Stock Down 0.4%

Shares of NASDAQ:YI opened at $5.26 on Monday. The company has a market cap of $46.24 million, a price-to-earnings ratio of -5.26 and a beta of 0.60. The firm’s 50-day simple moving average is $6.26 and its 200-day simple moving average is $5.59. 111, Inc. Sponsored ADR has a fifty-two week low of $2.48 and a fifty-two week high of $11.17.

Wall Street Analyst Weigh In

Separately, Weiss Ratings raised shares of 111 from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, May 21st. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, 111 currently has a consensus rating of “Sell”.

About 111

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.